President Donald Trump has announced a deal with Regeneron to lower the cost of its pharmaceutical products. The agreement, announced Thursday, includes lowering the prices of current and future drugs on Medicaid and selling a cholesterol drug for $225 on the White House’s discounted drug website, TrumpRx. The deal first reported by NOTUS is part of the Trump administration's efforts to provide economic relief to Americans ahead of the midterm elections. It's one of many deals the White House has struck that aim to align U.S. pharmaceutical prices with other developed nations. Details of these agreements remain undisclosed, but Health Secretary Robert F. Kennedy Jr. says nonproprietary information will be shared with Congress.
The benefits increase for nearly 71 million Social Security recipients will go into effect beginning in January.
The Louisville-based healthcare company was given until Sept. 24 to make the payment, according to a court filing.
Retired police officers, firefighters and teachers could see an estimated $300-$350 boost to their Social Security benefits beginning next month, according to Kentucky Education Association (KEA).
The ratings drop could equate to a $1.9 billion revenue hit in 2026.
The merger would have created a $140 billion giant in the health insurance industry.
This comes after Humana and Baptist Health Physicians failed to reach an agreement.
Remy Kennedy was in Washington, D.C. for a leadership summit with the ACS Action Network.
Baptist Health Medical Group doctors and advanced practice clinicians are no longer in network.